review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Thomas R | |
Pettit AR | |||
P2860 | cites work | Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells | Q24312985 |
Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products | Q24678867 | ||
Dendritic cells and the control of immunity | Q27860918 | ||
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
Molecular mimicry between non-self, modified self and self in autoimmunity | Q28266657 | ||
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand | Q42012073 | ||
Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization | Q42064511 | ||
Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig | Q42096363 | ||
New insights into the mobilization and phagocytic activity of dendritic cells | Q42142211 | ||
Mobilizing dendritic cells for tolerance, priming, and chronic inflammation | Q42576422 | ||
Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites | Q42971765 | ||
Dendritic cells hold promise for immunotherapy | Q43811691 | ||
Analysis of the histologic variation of synovitis in rheumatoid arthritis | Q44072100 | ||
Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry | Q45754853 | ||
Asymptomatic synovitis precedes clinically manifest arthritis | Q47685762 | ||
GM-CSF promotes differentiation of a precursor cell of monocytes and Langerhans-type dendritic cells from CD34+ haemopoietic progenitor cells | Q48020608 | ||
Differential nuclear localization of p50, p52, and RelB proteins in human accessory cells of the immune response in situ. | Q50335866 | ||
Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells | Q56338635 | ||
Expression of relB is required for the development of thymic medulla and dendritic cells | Q28594949 | ||
Cathepsin S required for normal MHC class II peptide loading and germinal center development | Q28611850 | ||
Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant | Q33368912 | ||
Are dendritic cells the key to liver transplant tolerance? | Q33542324 | ||
Molecular mimicry between host and pathogen: examples from parasites and implication | Q33610518 | ||
Molecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity | Q33630981 | ||
Coexpression of NF-kappa B/Rel and Sp1 transcription factors in human immunodeficiency virus 1-induced, dendritic cell-T-cell syncytia | Q33745081 | ||
Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. | Q33833912 | ||
Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines | Q34234920 | ||
Follicular dendritic cells as accessory cells | Q34274623 | ||
Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family | Q34317095 | ||
Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs | Q34756572 | ||
Distinct dendritic cell subsets differentially regulate the class of immune response in vivo | Q34950113 | ||
Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis | Q36028683 | ||
Differences in the level of expression of class I major histocompatibility complex proteins on thymic epithelial and dendritic cells influence the decision of immature thymocytes between positive and negative selection | Q36067105 | ||
The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells | Q36231530 | ||
A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis | Q36366458 | ||
Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. | Q36367475 | ||
CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo | Q36367705 | ||
Antigen-pulsed CD8alpha+ dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node. | Q36367734 | ||
Interaction of dendritic cells with skin endothelium: A new perspective on immunosurveillance | Q36367773 | ||
Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures | Q36376739 | ||
Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue | Q36404280 | ||
Dendritic cells in synovial fluid of chronic inflammatory arthritis lack CD80 surface expression | Q36677960 | ||
Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin | Q36822416 | ||
Functional CD40 ligand is expressed by T cells in rheumatoid arthritis | Q37374541 | ||
CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells | Q37698653 | ||
Analysis of T cell clones in rheumatoid arthritis | Q39538482 | ||
Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
Synovial fluid transforming growth factor beta inhibits dendritic cell-T lymphocyte interactions in patients with chronic arthritis | Q40965718 | ||
Cellular interactions in thymocyte development. | Q41039662 | ||
Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes | Q41121430 | ||
Presentation of self peptides by dendritic cells: possible implications for the pathogenesis of rheumatoid arthritis | Q41145666 | ||
A multistep molecular mimicry hypothesis for the pathogenesis of rheumatoid arthritis | Q41203065 | ||
Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? | Q41206012 | ||
Could endogenous self-peptides presented by dendritic cells initiate rheumatoid arthritis? | Q41305375 | ||
Biologic agents for treating rheumatoid arthritis. Concepts and progress | Q41398093 | ||
Regulation of osteoclast function | Q41486748 | ||
Thymic dendritic cells | Q41546347 | ||
The role of dendritic cells in T cell activation. | Q41550864 | ||
Absence of "original antigenic sin" in autoimmunity provides an unforeseen platform for immune therapy | Q41643784 | ||
Dendritic cell development: multiple pathways to nature's adjuvants | Q41664108 | ||
Apoptosis in rheumatoid arthritis: a novel pathway in the regulation of synovial tissue | Q41684607 | ||
Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells | Q41946843 | ||
P433 | issue | 5 | |
P921 | main subject | rheumatoid arthritis | Q187255 |
dendritic cell | Q506253 | ||
P304 | page(s) | 420-427 | |
P577 | publication date | 1999-10-01 | |
P1433 | published in | Immunology & Cell Biology | Q13731918 |
P1476 | title | Dendritic cells: the driving force behind autoimmunity in rheumatoid arthritis? | |
P478 | volume | 77 |
Q52026284 | Antigen-presenting cells in human periodontal disease tissues. |
Q33772722 | Berberine induces dendritic cell apoptosis and has therapeutic potential for rheumatoid arthritis |
Q78476270 | Co-stimulatory and adhesion molecules of dendritic cells in rheumatoid arthritis |
Q37082769 | Cysteine cathepsin S as an immunomodulatory target: present and future trends. |
Q93606932 | Dendritic Cells: What Is Their True Role in Rheumatoid Arthritis? |
Q44411888 | Dendritic cells in hyperplastic thymuses from patients with myasthenia gravis |
Q35161161 | Dendritic cells, T cell tolerance and therapy of adverse immune reactions |
Q34720552 | Destructive periodontitis lesions are determined by the nature of the lymphocytic response. |
Q36316921 | Drug delivery strategies for cathepsin inhibitors in joint diseases |
Q62065027 | Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis |
Q34896320 | Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis |
Q45492670 | Evidence for active antigen presentation by monocyte/macrophages in response to stimulation with particles: the expression of NFκB transcription factors and costimulatory molecules |
Q62748493 | FcγR expression on NK cells influences disease severity in rheumatoid arthritis |
Q35755276 | Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease |
Q24673314 | Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors |
Q41994013 | Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic mice. |
Q24647107 | Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes |
Q41841438 | MLN51 and GM-CSF involvement in the proliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis |
Q24806949 | Macrophages in rheumatoid arthritis |
Q33808073 | Monocyte Expressed Macromolecular C1 and C1q Receptors as Molecular Sensors of Danger: Implications in SLE |
Q36465475 | Recruitment of dendritic cells and macrophages during T cell-mediated synovial inflammation |
Q62065031 | Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections |
Q33723523 | Subcutaneous allergen immunotherapy restores human dendritic cell innate immune function |
Q24816880 | The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function |
Q53341131 | The type I IFN system in rheumatoid arthritis. |
Q37633537 | Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists |